Legal & General Group PLC Neuronetics, Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.35 - $4.66 $4,683 - $9,287	-1,993 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$2.09 - $3.71 $1,214 - $2,155	-581 Reduced 22.57%	1,993 $6,000
Q2 2021 Aug 12, 2021	BUY	$10.15 - $17.25 $26,126 - $44,401	2,574 New	2,574 $41,000
Q2 2020 Aug 14, 2020	SELL	$1.41 - $2.61 $3,794 - $7,023	-2,691 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$4.03 - $9.22 $2,139 - $4,895	531 Added 24.58%	2,691 $12,000
Q1 2019 May 15, 2019	BUY	$13.6 - $19.58 $16,184 - $23,300	1,190 Added 122.68%	2,160 $33,000
Q3 2018 Nov 20, 2018	BUY	$24.32 - $37.54 $23,590 - $36,413	970 New	970 $31,000

13.1M

30.1K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $32.4M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.